NYU Langone Orthopedics has become a national benchmark for clinical quality and patient safety, consistently reporting some of the nation’s lowest rates of hospital acquired conditions (HACs) and hospital-acquired venous thromboembolism (VTE).
“These outstanding metrics are not only a reflection of individual excellence, but of a system that empowers teams to deliver world-class care, safely and consistently,” says Joseph A. Bosco III, MD, director of quality and patient safety in the Department of Orthopedic Surgery.
“These outstanding metrics are not only a reflection of individual excellence, but of a system that empowers teams to deliver world-class care, safely and consistently.”
Joseph A. Bosco III, MD
“Our success reflects the ability to embed high standards across every patient interaction,” adds Dr. Bosco. “Sustaining excellent clinical outcomes is foundational to patient trust and organizational excellence.”
The department’s achievements are powered by a robust, data-driven quality improvement model focused on proactive risk assessment, strict adherence to evidence-based protocols, and real-time performance monitoring. This commitment to excellence has yielded sustained results—even as NYU Langone Orthopedics continues to grow across five hospitals and multiple ambulatory surgery centers (ASCs).
“As our footprint expands, so does our dedication to delivering safe, high-quality care,” says Dr. Bosco. “Our unwavering focus on patient outcomes ensures that innovation never comes at the expense of safety.”
